Papers

70 results
Cough peak flow to predict extubation outcome: a systematic review and meta-analysis.
Ferreira NA, Ferreira AS, Guimarães FS - Revista Brasileira de terapia intensiva, February 03, 2022 1 citations
P
pacientes que passed a spontaneous breathing trial
I/C
cough peak flow assessment, extubation outcome
O
diagnostic performance of the cough peak flow
EXTRA-SHORT IMPLANTS MAY BE A VIABLE ALTERNATIVE TO LONGER IMPLANTS WITH BONE AUGMENTATION IN ATROPHIC MAXILLARY AND MANDIBULAR RIDGES.
Radi IA, Hytham A - The journal of evidence-based dental practice, March 14, 2023 0 citations
P
Yu X, Xu R, Zhang Z, Yang Y, Deng F
I/C
extra-short implants (≤ 6‍ mm), longer implants (≥ 8‍ mm)
O
bone augmentation
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.
McBain C, Lawrie TA, Rogozińska E, Kernohan A, Robinson T, Jefferies S - The Cochrane database of systematic reviews, September 25, 2021 36 citations
P
I/C
O
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.
Meza N, Pérez-Bracchiglione J, Pérez I, Carvajal C, Ortiz-Muñoz L, Olguín P, Rada G, Madrid E, null null - Medwave, April 09, 2021 3 citations
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis.
Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, Reither K, Ross A - The Cochrane database of systematic reviews, June 08, 2021 6 citations
P
people being investigated for tuberculosis
I/C
Xpert MTB/RIF, smear microscopy
O
mortality, proportion of participants starting tuberculosis treatment who had a successful treatment outcome, proportion of participants who were treated for tuberculosis, proportion of participants with bacteriological confirmation who were lost to follow-up pre-treatment, proportion of treated participants who had bacteriological confirmation
Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period.
Abalos E, Sguassero Y, Gyte GM - The Cochrane database of systematic reviews, September 25, 2021 8 citations
P
I/C
O
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Burns J, Movsisyan A, Stratil JM, Coenen M, Emmert-Fees KM, Geffert K, Hoffmann S, Horstick O, Laxy M, Pfadenhauer LM, von Philipsborn P, Sell K, Voss S, Rehfuess E - The Cochrane database of systematic reviews, January 28, 2021 46 citations
P
I/C
O
Experiences and Perceptions in Dyads about Ostomy Care. Meta-synthesis of Qualitative Studies.
Quemba Mesa MP, Diaz Fernández JK, Vargas Rodríguez LY, Bautista Plazas L, Pulido Barragán SP - Investigacion y educacion en enfermeria, October 21, 2022 0 citations
P
care dyads, person with ostomy, caregiver
I/C
permanent discharge ostomy, no ostomy
O
rejection of bodily changes and sexual dysfunction, assertive and effective family care
Prednisolone/prednisone as adrenocorticotropic hormone alternative for infantile spasms: a meta-analysis of randomized controlled trials.
Li S, Zhong X, Hong S, Li T, Jiang L - Developmental medicine and child neurology, January 07, 2020 24 citations
P
616 participants
I/C
prednisolone/prednisone, ACTH/tetracosactide
O
electroclinical response, adverse events
Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M, Edwards S, Noel-Storr AH, McCleery J, Myint PK, Soiza R, Stewart C, Loke YK, Quinn TJ - The Cochrane database of systematic reviews, June 08, 2021 21 citations
P
older adults without cognitive impairment
I/C
anticholinergic medications, cognitive decline or dementia
O
risk of cognitive decline or dementia
CEO: Hwi-yeol YunCOO: Jung-woo ChaeCTO: Sangkeun Jung
Location: 204, W6, Chungnam National University, 99, Daehak-ro, Yuseong-gu, Daejeon, Republic of Korea
Tel: 042-821-7328E-mail: webmaster@lilac-co.kr
Copyright © 2024 by LiLac. All Rights Reserved.